Peter Böhlen
#153,734
Most Influential Person Now
Peter Böhlen's AcademicInfluence.com Rankings
Peter Böhlenbiology Degrees
Biology
#11686
World Rank
#15103
Historical Rank
Cell Biology
#602
World Rank
#615
Historical Rank
Genetics
#1270
World Rank
#1372
Historical Rank
Molecular Biology
#1827
World Rank
#1856
Historical Rank
Download Badge
Biology
Peter Böhlen's Degrees
- PhD Molecular Biology University of California, San Francisco
- Bachelors Biochemistry Stanford University
Why Is Peter Böhlen Influential?
(Suggest an Edit or Addition)Peter Böhlen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. (1992) (1590)
- Fluorometric assay of proteins in the nanogram range. (1973) (1413)
- Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. (1982) (1226)
- Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. (1987) (725)
- Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. (1985) (647)
- A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster (1988) (607)
- γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE 1 (1977) (447)
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. (1985) (364)
- Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. (1986) (356)
- Inhibitory action of transforming growth factor beta on endothelial cells. (1987) (331)
- Amino acid analysis with fluorescamine at the picomole level. (1973) (318)
- Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. (1984) (282)
- Transforming growth factor-beta inhibits endothelial cell proliferation. (1986) (282)
- Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy (1998) (281)
- Studies on the reaction of fluorescamine with primary amines. (1974) (259)
- THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM IN VIVO (1977) (213)
- Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. (1982) (209)
- Audiogenic seizure protection by elevated brain GABA concentration in mice: Effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors (1977) (204)
- Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). (1982) (201)
- Isolation and partial molecular characterization of pituitary fibroblast growth factor. (1984) (192)
- The relationship between GABA concentrations in brain and cerebrospinal fluid (1979) (192)
- Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. (1976) (190)
- Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. (1980) (172)
- Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. (1982) (169)
- Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. (1975) (168)
- Acidic fibroblast growth factor (FGF) from bovine brain: amino‐terminal sequence and comparison with basic FGF. (1985) (163)
- Purification of kidney epithelial cell growth inhibitors. (1980) (153)
- Primary structure of PDC-109, a major protein constituent of bovine seminal plasma. (1983) (150)
- Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. (1983) (149)
- Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. (1982) (148)
- Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. (1983) (130)
- Automated fluorometric amino acid analysis: the determination of proline and hydroxyproline. (1979) (126)
- Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. (1982) (122)
- Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. (1982) (122)
- Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): Partial chemical and biological characterization (1985) (120)
- Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. (1994) (119)
- Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain. (1983) (113)
- High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25 (1981) (110)
- VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. (1994) (109)
- High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides. (1982) (107)
- Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. (1982) (103)
- Fibroblast growth factor in the human placenta. (1985) (102)
- Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. (1983) (101)
- Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. (1983) (98)
- Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. (1997) (92)
- Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor (1985) (87)
- Studies on the kinetics of reaction and hydrolysis of fluorescamine. (1974) (85)
- Basic Fibroblast Growth Factor in the Adrenal Gland (1989) (83)
- Endothelial cell growth factors in embryonic and adult chick brain are related to human acidic fibroblast growth factor. (1988) (76)
- Cloning, characterization and developmental regulation of two members of a novel human gene family of neurite outgrowth-promoting proteins. (1991) (72)
- Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis. (1984) (69)
- Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. (1982) (68)
- Immunoreactive and biologically active growth hormone-releasing factor in the rat placenta. (1985) (68)
- HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function. (1991) (67)
- Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt. (2009) (67)
- Inactivation of the bovine mitochondrial F1-ATPase with dicyclohexyl[14C]carbodiimide leads to the modification of a specific glutamic acid residue in the beta subunit. (1981) (65)
- Isolation and characterization of rat pancreatic somatostatin. (1980) (63)
- Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis. (1994) (62)
- Two distinct mechanisms for ornithine decarboxylase regulation by polyamines in rat hepatoma cells (1979) (62)
- Automated assay of gamma-aminobutyric acid in human cerebrospinal fluid. (1978) (61)
- Somatocrinin, the growth hormone releasing factor. (1984) (61)
- Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25. (1980) (60)
- Growth hormone releasing factors. (1985) (60)
- Heparin-binding neurotrophic factor (HBNF) and MK, members of a new family of homologous, developmentally regulated proteins. (1990) (60)
- Acidic fibroblast growth factor is present in nonneural tissue: isolation and chemical characterization from bovine kidney. (1987) (59)
- Distinct tissue specific mitochondrial creatine kinases from chicken brain and striated muscle with a conserved CK framework. (1988) (58)
- Human brain fibroblast growth factor (1985) (57)
- Isolation and characterization of epidermal growth factor from human milk (1985) (57)
- Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study. (1992) (54)
- High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. (1996) (53)
- Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. (1981) (53)
- Signal transduction by bFGF, but not TGFβ1, involves arachidonic acid metabolism in endothelial cells (1991) (49)
- Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF (1986) (46)
- Isolation and structure of a novel C-terminally amidated opioid peptide, amidorphin, from bovine adrenal medulla (1985) (46)
- Growth Hormone-Releasing Factor: Chemistry and Physiology (1984) (45)
- Detection of fluorescamine-labeled amino acids, peptides, and other primary amines on thin-layer chromatograms (1974) (44)
- Amino acid analysis with fluorescamine of stained protein bands from polyacrylamide gels. (1974) (43)
- Skin polyamine levels in psoriasis: the effect of dithranol therapy * (1978) (40)
- Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro (1985) (40)
- Neuropeptides derived from prosomatostatin that do not contain the somatostatin-14 sequence (1984) (37)
- Isolation from bovine brain and structural characterization of HBNF, a heparin-binding neurotrophic factor. (1991) (37)
- Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors. (1977) (36)
- Isolation and characterization of a γ1‐melanotropin‐like peptide from bovine neurointermediate pituitary (1981) (35)
- A male accessory gland peptide with protease inhibitory activity in Drosophila funebris. (1989) (35)
- Reverse-phase high-performance liquid chromatography of proteins: the separation of hemoglobin chain variants. (1980) (34)
- A simplified protein assay with fluorescamine in samples containing interfering material. (1974) (33)
- Isolation and sequence of rat peptide YY and neuropeptide Y (1988) (33)
- Isolation and characterization of caprine corticotropin-releasing factor. (1984) (32)
- Primary structures of three human pancreas peptides with growth hormone-releasing activity. (1983) (32)
- A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. (1993) (32)
- Uptake and distribution of hexane in rat tissues. (1973) (30)
- Chemical characterization of the two forms of epidermal growth factor in murine saliva. (1984) (29)
- Isolation and chemical characterization of somatostatin-28 from rat hypothalamus (1981) (29)
- 1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopy (1995) (29)
- Analysis of vasopressin gene expression by in situ hybridization and immunohistochemistry in semi-thin sections. (1988) (29)
- Physiological studies with somatocrinin, a growth hormone-releasing factor. (1985) (26)
- Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis. (1984) (25)
- Analytical and preparative mapping of complex peptide mixtures reversed-phase high-performance liquid chromatography (1981) (25)
- Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. (1981) (25)
- Engineering of fibroblast growth factor: alteration of receptor binding specificity. (1995) (24)
- Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats. (1995) (21)
- The mitogenic activity of insulin: an intrinsic property of the molecule. (1980) (21)
- Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus. (1982) (20)
- Structure/Activity Relationships in Basic FGF (1991) (20)
- Amino acid sequence of human acidic fibroblast growth factor. (1986) (20)
- Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization (1983) (17)
- [Polyamines in psoriasis]. (1980) (16)
- Cerebrospinal fluid homocarnosine in Huntington's disease. (1980) (16)
- Refolding and characterization of human recombinant heparin-binding neurite-promoting factor. (1994) (16)
- The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. (1977) (15)
- Microisolation of neuropeptides. (1983) (14)
- Genomic organization of the human HBNF gene and characterization of an HBNF variant protein as a splice mutant. (1993) (14)
- Chemical and biological characterization of a truncated form of acidic fibroblast growth factor from bovine brain. (1986) (14)
- The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat (1980) (14)
- Purification from Brain of Synenkephalin, the N‐Terminal Fragment of Proenkephalin (1984) (13)
- Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF beta receptor subtype and decreases the growth inhibitory response to TGF-beta 1. (1990) (12)
- Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors (1986) (12)
- Comparison of the disulfide bond arrangements of human recombinant and bovine brain heparin binding neurite-promoting factors. (1993) (11)
- GABA and homocarnosine in CSF: The relationship to brain GABA content (1980) (8)
- Isolation and partial characterization of human T-cell growth factor. (1983) (8)
- Structure of the gene coding for the human retinoic acid-inducible factor, MK. (1993) (7)
- Development of a High Throughput Screening Assay for Inhibitors of Fibroblast Growth Factor-Receptor-Heparin Interactions (2001) (6)
- The relationship between GABA concentrations in brain and cerebrospinal fluid (1979) (6)
- Partial amino acid sequence of a somatostatin receptor isolated from GH4C1 pituitary cells. (1992) (6)
- [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells]. (1986) (5)
- Analysis for imino acids with o-phthalaldehyde. (1983) (5)
- Comparison of radioimmunoassay, chemical assay (HPLC) and bioassay for arginine vasopressin in synthetic standards and posterior pituitary tissue. (1982) (5)
- Anti-viral activity of human recombinant heparin-binding proteins HBNF and MK. (1992) (5)
- Chromosomal assignment of the heparin-binding cytokine genes MDK and PTN in mouse and man. (1995) (4)
- High-performance liquid chromatography in neuropeptide research. (1979) (4)
- Homocarnosine in the cerebrospinal fluid of patients with Huntington's disease (1980) (4)
- Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: High interspecies homology (1990) (4)
- A method for the unambiguous identification of tryptophan in automated protein sequence analysis. (1990) (3)
- Purification of the N-terminal fragment of proenkephalin from bovine adrenal medulla. (1983) (3)
- The effect of gamma-vinyl GABA and gamma-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat. (1980) (3)
- Isolation and Characterization of Opioid Peptides from Rabbit Cerebellum (1991) (2)
- Purification and N-terminal amino acid sequence of the human T90/44 (CD28) antigen (2004) (2)
- Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumour pseudocysts (2005) (2)
- [A method for the determination of hexane in blood and tissues of rats]. (1972) (1)
- 1301 – CORRELATION BETWEEN BRAIN AND CSF GABA LEVELS AFTER CENTRAL GABA-TRANSAMINASE INHIBITION (1978) (1)
- Treatment of Huntington disease with γ ‐acetylenic GABA, an irreversible inhibitor of GABA‐ transaminase (1981) (1)
- 4956455 Bovine fibroblast growth factor (1990) (0)
- Chimeric growth factor-fibrolast (1991) (0)
- [Acid-base equilibrium in the blood of rats following hexane inhalation]. (1973) (0)
- Vascular Endothelial Growth Factor (VEGF) Receptor 1 (VEGFR-1) and the VEGF Binding Protein (Extracellular Domain of VEGFR-1; s-Flt) are Involved in Regulating Ovarian Availability of VEGF for Folliculogenesis in the Rodent (2005) (0)
- Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-β type 1 (1992) (0)
- Process for producing a peptide having an impact on human and other mammalian hypofysekirtelfunktion (1983) (0)
- Analogifremgangsmaade for the preparation of pGRF pGRF analogs or peptides, pharmaceutically acceptable addition salts thereof as well as intermediate for use in the method (1983) (0)
- The Preovulatory Follicle Requires Signaling of Vascular Endothelial Growth Factor (VEGF) Through VEGF Receptor 2 (VEGFR-2) for Normal Functioning in the Non-Human Primate (2005) (0)
- The chimeric fibroblast growth factor (1991) (0)
- Biological Activity and Mechanisms of Action of Somatocrinin, Growth Hormone Releasing Factor, on the Release of Growth Hormone in Vitro and its Antagonism by Somatostatin (1984) (0)
- Preliminary X-ray crystallographic analysis of a modified basic fibroblast growth factor. (1991) (0)
- Active fragment of fibroblast growth factor (1991) (0)
- Molecular and biological characterization of fibroblast growth factor FGF, a potent inducer of angiogenesis (1987) (0)
- Csf gaba and homocarnosine concentrations in huntington's disease: Biochemical effect of treatment with γ-acetylenic Gaba (1979) (0)
- FREE GABA, GABA CONJUGATES AND HOMOCARNOSINE IN CSF: RELATIONSHIP TO BRAIN GABA (1980) (0)
- Growing factor for chimera fibroblast (1991) (0)
This paper list is powered by the following services:
